Visualising microglial activation in vivo
- PMID: 12379908
- DOI: 10.1002/glia.10144
Visualising microglial activation in vivo
Abstract
In health, microglia reside as quiescent guardian cells ubiquitously, but isolated without any cell-cell contacts amongst themselves, throughout the normal CNS. In disease, however, they act as swift "sensors" for pathological events, including subtle ones without any obvious structural damage. Once activated, microglia show a territorially highly restricted involvement in the disease process. This property, peculiar to microglia, confers to them diagnostic value for the accurate spatial localisation of any active disease process, acute or chronic. In the brain, the isoquinoline PK11195, a ligand for the peripheral benzodiazepine binding site (PBBS), binds with relative cellular selectivity to activated, but not resting, microglia. Labelled with carbon-11, (R)-PK11195 and positron emission tomography (PET) have been used for the study of inflammatory and neurodegenerative brain disease in vivo. These studies demonstrate meaningfully distributed patterns of regional [(11)C](R)-PK11195 signal increases that correlate with clinically observed loss of function. Increased [(11)C](R)-PK11195 binding closely mirrors the histologically well-described activation of microglia in the penumbra of focal lesions, as well as in the distant, anterograde, and retrograde projection areas of the lesioned neural pathway. There is also some indication that in long-standing alterations of a neural network with persistent abnormal input, additional signals of glial activation may also emerge in transsynaptic areas. These data suggest that the injured brain is less static than commonly thought and shows subtle glial responses even in macroanatomically stable appearing regions. This implies that glial activation is not solely a sign of tissue destruction, but possibly of disease-induced adaptation or plasticity as well. Whilst further technological and methodological advances are necessary to achieve routine clinical value and feasibility, a systematic attempt to image glial cells in vivo is likely to furnish valuable information on the cellular pathology of CNS diseases and their progression within the distributed neural architecture of the brain.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.Brain. 2000 Nov;123 ( Pt 11):2321-37. doi: 10.1093/brain/123.11.2321. Brain. 2000. PMID: 11050032
-
In vivo imaging of neuroinflammation.Eur Neuropsychopharmacol. 2002 Dec;12(6):581-6. doi: 10.1016/s0924-977x(02)00107-4. Eur Neuropsychopharmacol. 2002. PMID: 12468021 Review.
-
Positron emission tomography imaging of neuroinflammation.Neurotherapeutics. 2007 Jul;4(3):443-52. doi: 10.1016/j.nurt.2007.04.006. Neurotherapeutics. 2007. PMID: 17599710 Free PMC article. Review.
-
PK ('peripheral benzodiazepine')--binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia.J Neurocytol. 1997 Feb;26(2):77-82. doi: 10.1023/a:1018567510105. J Neurocytol. 1997. PMID: 9181482
-
Mitochondria in activated microglia in vitro.J Neurocytol. 2004 Sep;33(5):535-41. doi: 10.1007/s11068-004-0515-7. J Neurocytol. 2004. PMID: 15906160
Cited by
-
[11C]PBR28 PET imaging is sensitive to neuroinflammation in the aged rat.J Cereb Blood Flow Metab. 2015 Aug;35(8):1331-8. doi: 10.1038/jcbfm.2015.54. Epub 2015 Apr 1. J Cereb Blood Flow Metab. 2015. PMID: 25833342 Free PMC article.
-
Biomarkers for microglial activation in Alzheimer's disease.Int J Alzheimers Dis. 2011;2011:939426. doi: 10.4061/2011/939426. Epub 2011 Nov 1. Int J Alzheimers Dis. 2011. PMID: 22114747 Free PMC article.
-
The neuroinflammatory response in humans after traumatic brain injury.Neuropathol Appl Neurobiol. 2013 Oct;39(6):654-66. doi: 10.1111/nan.12008. Neuropathol Appl Neurobiol. 2013. PMID: 23231074 Free PMC article.
-
Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.J Neural Transm (Vienna). 2010 Aug;117(8):1019-25. doi: 10.1007/s00702-010-0431-6. Epub 2010 Jun 12. J Neural Transm (Vienna). 2010. PMID: 20549523 Review.
-
The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.Prog Neurobiol. 2006 Dec;80(6):308-22. doi: 10.1016/j.pneurobio.2006.10.002. Epub 2006 Dec 6. Prog Neurobiol. 2006. PMID: 17156911 Free PMC article. Review.
References
REFERENCES
-
- Alho H, Varga V, Krueger KE. 1994. Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth. Cell Growth Differ 9: 1005-1014.
-
- Anholt RR, Pedersen PL, DeSouza EB, Snyder SH. 1986. The peripheral-type benzodiazepine receptor. Localisation to the mitochondrial outer membrane. J Biol Chem 261: 776-783.
-
- Banati RB, Graeber MB. 1994. Surveillance, intervention and cytotoxicity: is there a protective role of microglia? Dev Neurosci 16: 114-127.
-
- Banati RB, Gehrman J, Schubert P, Kreutzberg GW. 1993. Cytotoxicity of microglia. Glia 7: 111-118.
-
- Banati RB, Myers R, Kreutzberg GW. 1997. PK (“peripheral benzodiazepine”)-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H] PK11195 binding to activated microglia. J Neurocytol 26: 77-82.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical